Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up 395 News Items found MSK Research Highlights, March 26, 2025 Wednesday, March 26, 2025 New MSK research develops a new tool for studying mitochondrial DNA deletions; uncovers mechanisms of histiocytosis-associated neurodegeneration; and investigates how mutant stem cells co-opt regeneration to make tumors grow. Q&A Meet Linde Miles, Winner of a Kravis WISE Postdoctoral Fellowship Monday, June 8, 2020 Dr. Miles is a postdoctoral fellow in the Human Oncology and Pathogenesis Program at MSK studying the genetics of blood cancers. The Tale of Abby's Tattoo: How She Beat Neuroblastoma Friday, September 10, 2021 Get to know Abby Hawk, who got a tattoo of Memorial Sloan Kettering after being treated there for neuroblastoma. ‘Long COVID’: MSK Scientists Search for Potential Autoimmune Causes Monday, May 24, 2021 A new resource provides a comprehensive list of human proteins that could trigger autoimmune symptoms in ‘long COVID’ patients. Memorial Sloan Kettering Researchers Build a New Model of Genetically Engineered Immune Cells That May Combat Solid Tumors in the Future Monday, August 13, 2018 Scientists at Memorial Sloan Kettering Cancer Center (MSK) announced that they have built a new model of genetically engineered immune cells in mice that may allow them to fight solid tumors. In the Lab Mind the Gap: Scientists Learn How Cells Make and Repair Tight Connections Wednesday, January 8, 2020 New findings from researchers at the Sloan Kettering Institute provide insight into a fundamental biological process called the epithelial-mesenchymal transition. Feature Sharing Love at MSK — One Card at a Time Tuesday, February 15, 2022 Cards are a longstanding Valentine’s tradition — and The Scarlett Fund, with help from Memorial Sloan Kettering Cancer Center employees, is using cards to make sure that patients and staff will be feeling the love for a long time to come. MSK Researchers Make Strides Against VEXAS Syndrome Monday, November 3, 2025 VEXAS syndrome is a confounding adult-onset inflammatory disease first described in 2020, which affects 1 in 4,000 men over 50. Now, MSK researchers are shedding new light on its mechanisms and laying the groundwork for potential targeted treatments. Fred’s Team Is Running Strong Despite Marathon Cancelation Wednesday, January 1, 2020 Read about Sandy Freiberg, who ran a marathon to honor his brother, Evan, who is in his fifth year of cancer treatment at Memorial Sloan Kettering. How MSK Is Teaching CAR T Cells To Attack Solid Tumors Tuesday, September 3, 2024 Read about the latest MSK research to make CAR T therapy effective against solid tumors. Pagination First page « First Previous page ‹ Previous … Page 32 Page 33 Page 34 Page 35 Page 36 Page 37 Current page 38 Page 39 Page 40 Next page Next › Last page Last » Book traversal links for Newsroom Previous Newsroom Next Cancer Vaccine Could Prevent Neuroblastoma From Returning After Antibody Treatment